Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date

M Nikoo, F Rabiee, H Mohebbi, N Eghbalifard… - International …, 2023 - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy, yielding
significant antitumor responses across multiple cancer types. Combination ICI therapy with …

Guillain‐Barre syndrome‐like polyneuropathy associated with immune checkpoint inhibitors: a systematic review of 33 cases

Y Li, X Zhang, C Zhao - BioMed Research International, 2021 - Wiley Online Library
Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of various
types of tumors with favorable results. But these treatments also led to a variety of immune …

Immune checkpoint inhibitor–related Guillain-Barré syndrome: a case series and review of the literature

JBE Janssen, TYS Leow, KH Herbschleb… - Journal of …, 2021 - journals.lww.com
Immune checkpoint inhibitors (ICIs) have been approved for the treatment of various
malignancies with promising clinical outcomes. Treatment can, however, be accompanied …

[PDF][PDF] Immune Checkpoint Inhibitor-Induced Guillain Barre Syndrome: A Single-Institution Case Report and Narrative Review

PO Idogun, S Hafez-Khayyata, D Ezekwudo - Cureus, 2024 - cureus.com
Guillain-Barré syndrome (GBS) resulting from the use of immune checkpoint inhibitors (ICIs)
is relatively uncommon but has been reported. Herein, we discuss a case of a 67-year-old …

肝細胞癌の多発肺転移に対してアテゾリズマブ・ベバシズマブ併用療法を導入し, ギラン・バレー症候群を来した一例

高橋実佑, 田中聡司, 笠倉至言, 渡邊和具, 原田理史… - 肝臓, 2023 - jstage.jst.go.jp
抄録 60 歳女性. 肝細胞癌多発肺転移に対してアテゾリズマブ・ベバシズマブ併用療法を開始した
14 日後から四肢末梢の感覚障害と四肢の筋力低下が出現した. 脳脊髄液検査では蛋白および …